Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Overview of attention for article published in Frontiers in oncology, February 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,550 followers.

New research: Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway: Combinational use of drugs has been a common strategy in cancer treatment because of… https://t.co/00h

26 Mar 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.